川芎和低分子右旋糖酐治疗急性脑梗塞的对照研究  

Comparative Study of Chuanxiong and Dextran 40 in the Treatment of Acute Cerebral Infarction

作　　者：陈达仁[1] 史荫绵[1] 田桂琴[1] 宫杰[1] 

机构地区：[1]上海第二军医大学附属长海医院神经科,上海200433

出　　处：《中国中西医结合杂志》1992年第2期71-73,共3页Chinese Journal of Integrated Traditional and Western Medicine

摘　　要：本文报告川芎和低分子右旋糖酐治疗经CT证实的急性脑梗塞患者220例的双盲对照研究。220例患者随机分为川芎组134例,低分子右旋糖酐组86例,根据神经功能和实际生活能力评分,结果川芎组总有效率为86.6%,低分子右旋糖酐组为62.8%,川芎对急性脑梗塞疗效高于低分子右旋糖酐。This paper reports the results of a double-blind trial in 220 patients with acute cerebral infarction evidenced by CT, who were randomly divided into Ligusticum chuanxiong group (134 cases) and low molecular weight dextran group (86 cases). A weighted scoring system was adopted to evaluate the neurologic function and living capability. The results showed that the total therapeutic efficacy rate in Chuanxiong group and in dextran 40 group were 86.6% and 62.8% respectively. The effect of Chuanxiong on the treatment of acute cerebral infarction was superior to low molecular weight dextran and the difference between the two groups was statistically significant (P<0.01).

关 键 词：川芎 右旋糖酐 脑栓塞 

分 类 号：R277.733.3[医药卫生—中医学]